Zymeworks Inc
NYSE:ZYME
Zymeworks Inc
Depreciation & Amortization
Zymeworks Inc
Depreciation & Amortization Peer Comparison
Competitive Depreciation & Amortization Analysis
Latest Figures & CAGR of Competitors
Company | Depreciation & Amortization | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Zymeworks Inc
NYSE:ZYME
|
Depreciation & Amortization
$10.2m
|
CAGR 3-Years
10%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Theratechnologies Inc
TSX:TH
|
Depreciation & Amortization
$2.9m
|
CAGR 3-Years
-31%
|
CAGR 5-Years
-12%
|
CAGR 10-Years
41%
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Depreciation & Amortization
$2m
|
CAGR 3-Years
29%
|
CAGR 5-Years
37%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Depreciation & Amortization
$1.3m
|
CAGR 3-Years
41%
|
CAGR 5-Years
65%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Depreciation & Amortization
$15.9m
|
CAGR 3-Years
108%
|
CAGR 5-Years
59%
|
CAGR 10-Years
30%
|
|
Spectral Medical Inc
TSX:EDT
|
Depreciation & Amortization
CA$220k
|
CAGR 3-Years
-12%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
See Also
What is Zymeworks Inc's Depreciation & Amortization?
Depreciation & Amortization
10.2m
USD
Based on the financial report for Dec 31, 2023, Zymeworks Inc's Depreciation & Amortization amounts to 10.2m USD.
What is Zymeworks Inc's Depreciation & Amortization growth rate?
Depreciation & Amortization CAGR 5Y
22%
Over the last year, the Depreciation & Amortization growth was 41%. The average annual Depreciation & Amortization growth rates for Zymeworks Inc have been 10% over the past three years , 22% over the past five years .